<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03641820</url>
  </required_header>
  <id_info>
    <org_study_id>FJZL20180407</org_study_id>
    <nct_id>NCT03641820</nct_id>
  </id_info>
  <brief_title>Cognitive Dysfunction in Patients With Cancer Pain</brief_title>
  <official_title>Correlative Factors of Cognitive Dysfunction in Patients With Cancer Pain: a Cross-sectional Study From China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fujian Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fujian Cancer Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the occurrence of cognitive dysfunction in cancer patients with pain in&#xD;
      China.Analysis of patients with different cancer pain, different analgesic drugs and&#xD;
      different treatments are associated with the severity of cognitive dysfunction, to provide&#xD;
      relevant evidence for the next screening, prediction, prevention and treatment. In order to&#xD;
      achieve the purpose of improving the quality of life of cancer patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cross-sectional survey in patients with cancer pain is used in the outpatient clinics and&#xD;
      wards of five cancer hospitals in China.&#xD;
&#xD;
      This study is to survey the incidence of cognitive dysfunction in Chinese cancer patients,&#xD;
      and the related factors of cognitive dysfunction, demographic characteristics (economic&#xD;
      situation, education, gender, age), disease status (tumor type, staging) ), analgesic&#xD;
      treatment (NRS score, with or without analgesic drugs, analgesic drug name, dose), anti-tumor&#xD;
      treatment (with or without anti-tumor treatment, surgery, radiotherapy, chemotherapy, time&#xD;
      interval from last treatment, chemotherapy drugs) and so on.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">August 21, 2018</start_date>
  <completion_date type="Anticipated">February 28, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Prevalence of Cancer-related cognitive dysfunction patient with pain</measure>
    <time_frame>6 months</time_frame>
    <description>Statistical analysis was performed SPSS 21.0. The t test was used for comparison between groups, and the X2 test was used for the count data. The logistic regression model was used for multivariate analysis. The regression coefficient, P value and OR value were calculated by age, ethnicity, education level, treatment plan and income as covariates.</description>
  </primary_outcome>
  <enrollment type="Anticipated">928</enrollment>
  <condition>Cognitive Dysfunction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Malignant tumor patient with pain&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Malignant tumor patient with pain are confirmed by histopathology or cytology (NRS&#xD;
             score ≥ 1);&#xD;
&#xD;
          -  Understand Chinese through verbal and written communication, read and write Chinese,&#xD;
             numbers, and complete questionnaire surveys;&#xD;
&#xD;
          -  Male or female, age 18-75 years old;&#xD;
&#xD;
          -  ECOG 0-2, expected to survive for more than 3 months;&#xD;
&#xD;
          -  no obvious dysfunction of heart, lung, liver, kidney, blood system (≤I degree);&#xD;
&#xD;
          -  patients voluntarily sign informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women and lactating women.&#xD;
&#xD;
          -  Also participate in clinical trials of drugs that have not been approved for&#xD;
             marketing.&#xD;
&#xD;
          -  Patients with depression (evaluated by the Hamilton Depression Scale).&#xD;
&#xD;
          -  Active bleeding or bleeding tendency.&#xD;
&#xD;
          -  Serious or uncontrolled medical conditions and infected people.&#xD;
&#xD;
          -  Patients with structural heart disease, such as coronary heart disease, unstable&#xD;
             angina, especially patients with congestive heart failure and atrial fibrillation,&#xD;
             atrial flutter history, and patients with hypertension, hypercoagulable state and&#xD;
             severe cerebrovascular disease.&#xD;
&#xD;
          -  History of thromboembolic disease; long-term oral administration of aspirin and other&#xD;
             anticoagulants.&#xD;
&#xD;
          -  Preventive Whole Brain Irradiation (PCI).&#xD;
&#xD;
          -  Bone marrow invasion or bone marrow metastasis.&#xD;
&#xD;
          -  Patients with severe or uncontrollable mental illness.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>huiyu luo</last_name>
    <phone>13799365820</phone>
    <email>13799365820@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Nursing, Fujian Provincial Cancer Hospital</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350014</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>huiyu luo</last_name>
      <phone>13799365820</phone>
      <email>13799365820@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 20, 2018</study_first_submitted>
  <study_first_submitted_qc>August 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2018</study_first_posted>
  <last_update_submitted>August 21, 2018</last_update_submitted>
  <last_update_submitted_qc>August 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cancer Pain</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

